Loading clinical trials...

Cefiderocol in the Treatment of Multidrug-resistant Gram-negative Bacilli Infections, a Retrospective Study | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT05544682

Cefiderocol in the Treatment of Multidrug-resistant Gram-negative Bacilli Infections, a Retrospective Study

Cefiderocol is a new antibiotic from the siderophore cephalosporin family for which there are few real-life data on its use in the treatment of infections with multidrug-resistant Gram-negative bacill...

Lead sponsor: University Hospital, Strasbourg, France•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Yvon RUCH, MD

CONTACT

33 3 69 55 05 45 [email protected]

Related studies

RECRUITINGPhase 2

PMT for MDRO Decolonization

NCT05632315 · Multidrug Resistant Bacterial Infection, Enterobacteriaceae Infections, and more

Enrolling By Invitation

Multi-resistant and Spore-forming Bacteria in a Neonatal Intensive Care Unit

NCT06391463 · Multidrug Resistant Bacterial Infection

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 19, 2023Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment15

Start dateSep 2022

Last updatedDec 19, 2023

Condition

Multidrug Resistant Bacterial Infection

Locations shown

Service des maladies infectieuses et tropicales - CHU de Strasbourg - France

Strasbourg

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 19, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions